- Corporate Officers - B
- Bios Advisors Gp, Llc
Insider Trading History of Bios Advisors Gp, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bios Advisors Gp, Llc since 2022.
This trader's CIK number is 1813844.
At the time of last reporting, Bios Advisors Gp, Llc was the Officer of Lantern Pharma Inc.. (stock ticker symbol LTRN).
Also see all insider trading activities at Lantern Pharma Inc..
Note that in the past
BIOS Advisors GP, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at In8bio, Inc. (INAB) by Bios Advisors Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | INAB | 1,923,685 | $3,702,951 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lantern Pharma Inc. (LTRN) by Bios Advisors Gp, Llc
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LTRN | 0 | $0 | 157,850 | $500,287 | 0 | $0 |
| 2024 | LTRN | 0 | $0 | 232,889 | $1,112,726 | 0 | $0 |
| 2023 | LTRN | 0 | $0 | 145,348 | $499,997 | 0 | $0 |
| 2022 | LTRN | 0 | $0 | 350,000 | $1,540,000 | 0 | $0 |
Insider trading activities at 2 companies by Bios Advisors Gp, Llc:
1. In8bio, Inc. (INAB)
2. Lantern Pharma Inc. (LTRN)
Table 1. Insider trading of In8bio, Inc. (INAB) by Bios Advisors Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-12 | INAB | Buy | 75,001 | 2.48 | 185,927 |
| 2022-09-28 | INAB | Buy | 25,000 | 2.02 | 50,525 |
| 2022-08-17 | INAB | Buy | 50,000 | 1.93 | 96,500 |
| 2022-08-16 | INAB | Buy | 1,773,684 | 1.90 | 3,369,999 |
Table 2. Insider trading of Lantern Pharma Inc. (LTRN) by Bios Advisors Gp, Llc
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-13 | LTRN | Sale | 40,000 | 3.09 | 123,600 |
| 2025-06-10 | LTRN | Sale | 16 | 3.40 | 54 |
| 2025-06-11 | LTRN | Sale | 950 | 3.40 | 3,230 |
| 2025-06-12 | LTRN | Sale | 60,647 | 3.38 | 204,986 |
| 2025-05-28 | LTRN | Sale | 15,000 | 2.87 | 43,050 |
| 2025-05-29 | LTRN | Sale | 20,200 | 3.03 | 61,205 |
| 2025-05-27 | LTRN | Sale | 21,037 | 3.05 | 64,162 |
| 2024-05-23 | LTRN | Sale | 10,000 | 6.25 | 62,500 |
| 2024-05-24 | LTRN | Sale | 20,000 | 6.33 | 126,600 |
| 2024-02-27 | LTRN | Sale | 50,000 | 4.40 | 220,000 |
| 2024-02-28 | LTRN | Sale | 74,297 | 4.85 | 360,340 |
| 2024-02-29 | LTRN | Sale | 19,703 | 4.87 | 95,953 |
| 2024-01-17 | LTRN | Sale | 58,889 | 4.20 | 247,333 |
| 2023-11-29 | LTRN | Sale | 145,348 | 3.44 | 499,997 |
| 2022-11-08 | LTRN | Sale | 350,000 | 4.40 | 1,540,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bios Advisors Gp, Llc
(Officer of Lantern Pharma Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.